Predictive Factors and Clinical Markers of Recurrent Wheezing and Asthma After RSV Infection
Viruses · 2025
DOI: 10.3390/v17081073 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Viruses, 2025. Verfasst von Luca Buttarelli und 6 weiteren Autor:innen. Beteiligte Einrichtung: Pediatric Clinic, Pietro Barilla Children's Hospital, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy. Hauptthemen laut MEDLINE: Respiratory Syncytial Virus Infections, Asthma, Respiratory Sounds. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 81 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NextGenerationEU-MUR M4C2.I.1.3 PNRR, One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases.
Abstract (Originalsprache)
Respiratory syncytial virus (RSV) is a major cause of acute lower respiratory infections (ALRIs) in young children, especially bronchiolitis, with significant global health and economic impact. Increasing evidence links early-life RSV infection to long-term respiratory complications, notably recurrent wheezing and asthma. This narrative review examines these associations, emphasizing predictive factors and emerging biomarkers for risk stratification. Early RSV infection can trigger persistent airway inflammation and immune dysregulation, increasing the likelihood of chronic respiratory outcomes. Risk factors include severity of the initial infection, age at exposure, genetic susceptibility, prematurity, air pollution, and tobacco smoke. Biomarkers such as cytokines and chemokines are showing promise in identifying children at higher risk, potentially guiding early interventions. RSV-related bronchiolitis may also induce airway remodeling and promote Th2/Th17-skewed immune responses, mechanisms closely linked to asthma development. Advances in molecular profiling are shedding light on these pathways, suggesting novel targets for early therapeutic strategies. Furthermore, passive immunization and maternal vaccination offer promising approaches to reducing both acute and long-term RSV-related morbidity. A deeper understanding of RSV’s prolonged impact is essential to develop targeted prevention, enhance risk prediction, and improve long-term respiratory health in children. Future studies should aim to validate biomarkers and refine immunoprophylactic strategies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Pediatric Clinic, Pietro Barilla Children's Hospital, Department of Medicine and Surgery, University Hospital of Parma, 43126 Parma, Italy.
- Pediatric Unit, Department of Human Pathology in Adult and Developmental Age "Gaetano Barresi", University of Messina, 98124 Messina, Italy.
ORCID-Profile: Antonella Gambadauro, Sara Manti, Susanna Esposito
Förderung
- NextGenerationEU-MUR M4C2.I.1.3 PNRR
- One Health Basic and Translational Research Actions addressing Unmet Needs on Emerging Infectious Diseases
Zitieren
APA
Buttarelli, L., Caselli, E., Gerevini, S., Leuratti, P., Gambadauro, A., Manti, S., & Esposito, S. (2025). Predictive Factors and Clinical Markers of Recurrent Wheezing and Asthma After RSV Infection. Viruses. https://doi.org/10.3390/v17081073
Vancouver
Buttarelli L, Caselli E, Gerevini S, Leuratti P, Gambadauro A, Manti S, et al. Predictive Factors and Clinical Markers of Recurrent Wheezing and Asthma After RSV Infection. Viruses. 2025. doi:10.3390/v17081073
BibTeX
@article{Buttarelli2025,
author = {Buttarelli, Luca and Caselli, Elisa and Gerevini, Sofia and Leuratti, Pietro and Gambadauro, Antonella and Manti, Sara and Esposito, Susanna},
title = {Predictive Factors and Clinical Markers of Recurrent Wheezing and Asthma After RSV Infection},
journal = {Viruses},
year = {2025},
doi = {10.3390/v17081073}
}
EUVIMED